[Clinical evaluation of Trivé 1000 in surgery].
Trials with Trive 1000 allow to confirm its perfect tolerance and its real interest in N sparing effect provided a minimum of 1500 ml, or even better 2000 ml are perfused with an adequate caloric carboyhdrate complement. However, in severe cases such as septicemia, one may expect a positive N balance only with much more important supply of N and calories. Since there is almost no change in parameters refleting fat metabolism, one may suppose a normal utilisation of injected fat.
D000328:Adult; D000368:Aged; D000596:Amino Acids / Q000097:blood / Q000378:metabolism; D050260:Carbohydrate Metabolism; D002241:Carbohydrates / Q000097:blood; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004338:Drug Combinations; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009584:Nitrogen / Q000378:metabolism; D010288:Parenteral Nutrition; D013514:Surgical Procedures, Operative
D000596:Amino Acids; D002241:Carbohydrates; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004338:Drug Combinations; D008055:Lipids; C012657:Trive 1000; D009584:Nitrogen
Essais cliniques du Trivé 1000 en chirurgie